Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q82860693)
Watch
English
Dual ACE/NEP inhibitors - more than playing the ACE card
scientific article published on 16 March 2006
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16543904
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16543904%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
title
Dual ACE/NEP inhibitors - more than playing the ACE card
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16543904
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16543904%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
author name string
Jandeleit-Dahm KA
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16543904
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16543904%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
publication date
16 March 2006
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16543904
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16543904%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
published in
Journal of Human Hypertension
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16543904
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16543904%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
volume
20
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16543904
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16543904%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
issue
7
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16543904
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16543904%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
page(s)
478-481
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16543904
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16543904%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
exact match
https://scigraph.springernature.com/pub.10.1038/sj.jhh.1002018
0 references
cites work
The clinical, cardiac, renal, arterial and neurohormonal effects of omapatrilat, a vasopeptidase inhibitor, in patients with chronic heart failure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Assessment of tissue iron overload by nuclear magnetic resonance imaging
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronic inhibition of endopeptidase 24.11 in essential hypertension: evidence for enhanced atrial natriuretic peptide and angiotensin II
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antihypertensive and antihypertrophic effects of omapatrilat in SHR
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vasopeptidase inhibition reverses myocardial vasoactive intestinal peptide depletion and decreases fibrosis in salt sensitive hypertension
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardiorenal protective effects of vasopeptidase inhibition with omapatrilat in hypertensive transgenic (mREN-2)27 rats
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vasopeptidase inhibition in heart failure.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neutral endopeptidase and angiotensin-converting enzyme inhibitors increase nitric oxide production in isolated canine coronary microvessels by a kinin-dependent mechanism
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dual angiotensin-converting enzyme/neutral endopeptidase inhibition on cardiac and renal fibrosis and inflammation in DOCA-salt hypertensive rats
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The cardioprotective effect of dual metallopeptidase inhibition: respective roles of endogenous kinins and natriuretic peptides
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardiac and renal effects of omapatrilat, a vasopeptidase inhibitor, in rats with experimental congestive heart failure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-atherosclerotic and renoprotective effects of combined angiotensin-converting enzyme and neutral endopeptidase inhibition in diabetic apolipoprotein E-knockout mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Omapatrilat decreased macrophage oxidative status and atherosclerosis progression in atherosclerotic apolipoprotein E-deficient mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Design of the omapatrilat in persons with enhanced risk of atherosclerotic events (OPERA) trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Triple vasopeptidase inhibition normalizes blood pressure in conscious, unrestrained, and spontaneously hypertensive rats
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.JHH.1002018
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1038/SJ.JHH.1002018
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16543904
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16543904%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
Dimensions Publication ID
1027025668
0 references
PubMed publication ID
16543904
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16543904
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16543904%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit